НовостиBenzingaCitigroup Maintains Buy on Attovia Therapeutics, Raises Price Target to $34 Citigroup Maintains Buy on Attovia Therapeutics, Raises Price Target to $34 Benzinga 2026.11.10 20:09 (GMT+0) Открыть на Benzinga Другие новости